TRIAXOVED

Product Description

TRIAXOVED is formulated with Ceftriaxone, a broad-spectrum third-generation cephalosporin, combined with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone is bactericidal, inhibiting bacterial cell wall synthesis and acting against a wide range of Gram-positive and Gram-negative organisms. Sulbactam protects ceftriaxone from degradation by bacterial beta-lactamase enzymes, extending its activity against beta-lactamase-producing bacteria that would otherwise be resistant.

Key Benefits:

  • Broad-spectrum, potent bactericidal activity against both Gram-positive and Gram-negative bacteria.
  • Sulbactam protects ceftriaxone from beta-lactamase-mediated degradation, extending its effective spectrum.
  • Third-generation cephalosporin with strong tissue penetration.

Description

Indications — When to Administer TRIAXOVED:

  • Severe or life-threatening bacterial infections caused by susceptible Gram-positive or Gram-negative organisms.
  • Infections resistant to first-line, lower-tier antibiotics, where culture and sensitivity testing supports use.
  • Confirmed or strongly suspected infection with a susceptible organism, as directed by a veterinarian.

PRESENTATION:

  • 3 g Vial with WFI (Water for Injection)
Go to Top